SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gene therapy

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (75)6/22/1999 1:48:00 AM
From: SnowShredder  Read Replies (1) of 319
 
Hi Rick,
Also @ the ASGT meeting in DC Jeff Isner presented some his results using VEGF-165 on people. He directly injected 250 micrograms of DNA into patients that suffered from ulcer/gangrene. He was able to get good response in that only one patient out of ? needed to get their limb amputated, the rest had enough vascular growth to keep their limbs.

He also did a cardiac study via catheter...after 6 months >50% were free from angina...and that the patients that were class IV @ the begining of the study were class I/II @ the end.

Sounds promising to me. Now to figure out which company uses VEGF-165. Best of luck, Where'd He Go?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext